Balance Sheet Lee & Man Chemical Company Limited

Equities

746 KYG5427E1145

Commodity Chemicals

Market Closed - Hong Kong S.E. Other stock markets 04:08:24 2025-06-20 am EDT			5-day change	1st Jan Change
3.700 ^HKD	+0.82%		+2.21%	-0.80%

Mar. 05	Lee & Man Chemical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
2024	Lee & Man Chemical Company Limited(SEHK:746) dropped from S&P Global BMI Index	CI

8c79a9c389801c5b8cb.chlcmzU8qawWrYI-mgTEoiAnPi_1LQBSWcu9hqInhBw.EGoGznx2xppJ1fpX1Hz91UFEBlqtGVoXM5rU3JFI5l9BfCvTeAWf1HLjtg

Published financial data: LEE & MAN CHEMICAL COMPANY LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	3.1B	5.19B	5.87B	4.05B	3.95B
Total Revenues	3.1B	5.19B	5.87B	4.05B	3.95B
Cost of Goods Sold, Total	1.97B	2.85B	3.74B	2.99B	2.79B
Gross Profit	1.13B	2.34B	2.12B	1.06B	1.16B
Selling General & Admin Expenses, Total	425M	532M	531M	468M	478M
R&D Expenses	154M	231M	204M	121M	136M
Other Operating Expenses, Total	578M	763M	735M	589M	614M
Operating Income	553M	1.58B	1.39B	473M	551M
Interest Expense, Total	-55.85M	-47.62M	-38.66M	-39.28M	-21.9M
Interest And Investment Income	5.98M	4.79M	5.9M	4.54M	4.58M
Net Interest Expenses	-49.87M	-42.83M	-32.76M	-34.75M	-17.31M
Income (Loss) On Equity Invest.	-8.69M	-1.24M	312K	543K	3.69M
Currency Exchange Gains (Loss)	42.22M	23.25M	-21.01M	-6.98M	2.35M
Other Non Operating Income (Expenses)	91M	61.15M	60.95M	75.41M	58.31M
EBT, Excl. Unusual Items	628M	1.62B	1.4B	508M	598M
Gain (Loss) On Sale Of Investments	1.03M	-3.09M	5.17M	-2.11M	1.09M
Gain (Loss) On Sale Of Assets	-789K	-1.7M	-2.79M	-2.67M	-2.44M
Asset Writedown	-	-	-	-8.84M	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	628M	1.61B	1.4B	494M	596M
Income Tax Expense	125M	323M	241M	93.23M	114M
Earnings From Continuing Operations	503M	1.29B	1.16B	401M	482M
Net Income to Company	503M	1.29B	1.16B	401M	482M
Minority Interest	-	-	-	-	-
Net Income - (IS)	503M	1.29B	1.16B	401M	482M
Net Income to Common Incl Extra Items	503M	1.29B	1.16B	401M	482M
Net Income to Common Excl. Extra Items	503M	1.29B	1.16B	401M	482M
Per Share Items
Net EPS - Basic	0.61	1.56	1.4	0.49	0.58
Basic EPS - Continuing Operations	0.61	1.56	1.4	0.49	0.58
Basic Weighted Average Shares Outstanding	825M	825M	825M	825M	825M
Net EPS - Diluted	0.61	1.51	1.34	0.48	0.58
Diluted EPS - Continuing Operations	0.61	1.51	1.34	0.48	0.58
Diluted Weighted Average Shares Outstanding	825M	854M	861M	838M	825M
Normalized Basic EPS	0.48	1.22	1.06	0.38	0.45
Normalized Diluted EPS	0.48	1.18	1.01	0.38	0.45
Dividend Per Share	0.24	0.58	0.55	0.19	0.29
Payout Ratio	36.93	27.22	49.92	45.3	47.89
Supplemental Items
EBITDA	600M	1.63B	1.46B	532M	624M
EBITA	556M	1.58B	1.39B	476M	553M
EBIT	553M	1.58B	1.39B	473M	551M
EBITDAR	-	1.63B	1.46B	532M	624M
Total Revenues (As Reported)	-	-	5.87B	4.05B	3.95B
Effective Tax Rate - (Ratio)	19.98	20.05	17.26	18.88	19.11
Current Domestic Taxes	124M	322M	267M	126M	124M
Total Current Taxes	124M	322M	267M	126M	124M
Deferred Domestic Taxes	9.46M	14.86M	-4.04M	-29.63M	2.92M
Total Deferred Taxes	9.46M	14.86M	-4.04M	-29.63M	2.92M
Normalized Net Income	392M	1.01B	872M	317M	373M
Interest Capitalized	2.59M	1.96M	-	-	-
Interest on Long-Term Debt	71K	235K	159K	58K	180K
Supplemental Operating Expense Items
Selling and Marketing Expenses	201M	233M	254M	209M	203M
General and Administrative Expenses	223M	299M	277M	259M	275M
Research And Development Expense From Footnotes	157M	234M	207M	123M	138M
Net Rental Expense, Total	-	315K	205K	144K	126K
Imputed Operating Lease Interest Expense	-	97K	71.08K	63.5K	33.14K
Imputed Operating Lease Depreciation	-	218K	134K	80.5K	92.86K
Stock-Based Comp., Other (Total)	32.78M	32.68M	8.06M	-	-
Total Stock-Based Compensation	32.78M	32.68M	8.06M	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	387M	325M	422M	264M	223M
Short Term Investments	-	-	-	-	67.88M
Total Cash And Short Term Investments	387M	325M	422M	264M	291M
Accounts Receivable, Total	256M	373M	225M	299M	369M
Other Receivables	37.8M	49.28M	53.34M	38.61M	74.7M
Notes Receivable	14.97M	15.52M	14.2M	11.08M	-
Total Receivables	309M	438M	293M	349M	443M
Inventory	504M	762M	844M	788M	601M
Prepaid Expenses	103M	87.14M	43.17M	88.72M	43.03M
Restricted Cash	36.04M	-	-	-	-
Other Current Assets, Total	441M	534M	107M	23.81M	9.36M
Total Current Assets	1.78B	2.15B	1.71B	1.51B	1.39B
Gross Property Plant And Equipment	6.99B	7.94B	7.73B	8.1B	8.83B
Accumulated Depreciation	-2.3B	-2.75B	-2.85B	-3.2B	-3.5B
Net Property Plant And Equipment	4.69B	5.19B	4.88B	4.9B	5.33B
Long-term Investments	127M	132M	123M	123M	125M
Goodwill	2.79M	2.9M	2.62M	2.59M	2.54M
Other Intangibles, Total	98.66M	99.3M	87.53M	83.88M	79.46M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	23.09M	23.37M	20.65M	19.91M	18.98M
Other Long-Term Assets, Total	55.05M	20.36M	252M	384M	255M
Total Assets	6.78B	7.62B	7.08B	7.03B	7.2B
Liabilities
Accounts Payable, Total	224M	198M	195M	167M	167M
Accrued Expenses, Total	72.67M	69.67M	57.62M	29.38M	45.42M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	459M	433M	523M	672M	588M
Current Portion of Leases	2.38M	2.18M	2.4M	2.36M	2.31M
Current Income Taxes Payable	49.42M	160M	37.98M	46.17M	11.24M
Unearned Revenue Current, Total	135M	121M	66.47M	59.1M	41.45M
Other Current Liabilities	232M	356M	252M	196M	291M
Total Current Liabilities	1.17B	1.34B	1.13B	1.17B	1.15B
Long-Term Debt	1.07B	600M	221M	-	60.44M
Long-Term Leases	4.21M	2.19M	71K	4.79M	2.38M
Unearned Revenue Non Current	23.88M	29.56M	27.3M	19.06M	17.29M
Deferred Tax Liability Non Current	50.02M	65.88M	58.18M	27.71M	29.68M
Other Non Current Liabilities	9.47M	6.5M	3.11M	5.84M	4.51M
Total Liabilities	2.34B	2.04B	1.44B	1.23B	1.26B
Common Stock, Total	82.5M	82.5M	82.5M	82.5M	82.5M
Additional Paid In Capital	20.31M	20.31M	20.31M	20.31M	20.31M
Retained Earnings	4.29B	5.23B	5.81B	1.03B	6.28B
Comprehensive Income and Other	47.7M	242M	-279M	4.66B	-446M
Total Common Equity	4.44B	5.57B	5.63B	5.8B	5.94B
Minority Interest	-	-	-	-	-
Total Equity	4.44B	5.57B	5.63B	5.8B	5.94B
Total Liabilities And Equity	6.78B	7.62B	7.08B	7.03B	7.2B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	825M	825M	825M	825M	825M
ECS Total Common Shares Outstanding	825M	825M	825M	825M	825M
Book Value / Share	5.39	6.76	6.83	7.03	7.2
Tangible Book Value	4.34B	5.47B	5.54B	5.71B	5.85B
Tangible Book Value Per Share	5.26	6.63	6.72	6.93	7.1
Total Debt	1.54B	1.04B	746M	679M	653M
Net Debt	1.15B	712M	325M	415M	362M
Debt Equivalent Oper. Leases	-	2.52M	1.64M	1.15M	1.01M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	127M	132M	123M	123M	125M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	374M	502M	522M	531M	428M
Inventories - Work In Process, Total	31.94M	53.24M	47.23M	41.06M	25.65M
Inventories - Finished Goods, Total	98.37M	207M	275M	215M	147M
Land - (BS)	605M	748M	733M	722M	-
Buildings, Total	-	-	-	-	754M
Machinery, Total	5.52B	6.48B	6.06B	6.26B	6.27B
Full Time Employees	2.1K	2.1K	2.25K	2.1K	1.93K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	503M	1.29B	1.16B	401M	482M
Depreciation & Amortization - CF	48.56M	54.2M	74.1M	61.74M	76.51M
Amortization of Goodwill and Intangible Assets - (CF)	2.62M	2.82M	2.8M	2.64M	2.58M
Depreciation & Amortization, Total	51.18M	57.02M	76.9M	64.38M	79.09M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	789K	1.7M	2.79M	2.67M	2.44M
(Gain) Loss on Sale of Investments - (CF)	-1.03M	3.09M	-5.17M	2.11M	-
Asset Writedown & Restructuring Costs	-	-	-	8.84M	-
(Income) Loss On Equity Investments - (CF)	8.69M	1.24M	-312K	-543K	-3.69M
Stock-Based Compensation (CF)	32.78M	32.68M	8.06M	-	-
Other Operating Activities, Total	22.41M	166M	63.69M	25.82M	-9.89M
Change In Accounts Receivable	-17.89M	-36.5M	193M	-56.91M	-50.13M
Change In Inventories	180M	-78.91M	289M	455M	531M
Change In Accounts Payable	21.9M	244M	-130M	-131M	40.07M
Change in Unearned Revenues	74.35M	-10.88M	-54.86M	-9.54M	-18.75M
Change in Other Net Operating Assets	3.22M	-188M	-568K	-5.02M	3.52M
Cash from Operations	880M	1.48B	1.6B	756M	1.06B
Capital Expenditure	-479M	-673M	-611M	-548M	-765M
Sale of Property, Plant, and Equipment	1.77M	914K	1.98M	356K	485K
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Real Estate properties	-	-	-	-9.21M	-
Sale (Purchase) of Intangible assets	-	-	-380K	-	-
Investment in Marketable and Equity Securities, Total	542K	-4.65M	-1.11M	4.87M	-57.45M
Other Investing Activities, Total	-1.2M	40.33M	5.9M	-61.61M	-4.68M
Cash from Investing	-477M	-636M	-605M	-614M	-826M
Long-Term Debt Issued, Total	694M	1.13B	225M	834M	762M
Total Debt Issued	694M	1.13B	225M	834M	762M
Long-Term Debt Repaid, Total	-704M	-1.65B	-488M	-912M	-775M
Total Debt Repaid	-704M	-1.65B	-488M	-912M	-775M
Common Dividends Paid	-186M	-351M	-578M	-182M	-231M
Common & Preferred Stock Dividends Paid	-186M	-351M	-578M	-182M	-231M
Other Financing Activities, Total	-58.44M	-49.58M	-38.5M	-39.28M	-21.9M
Cash from Financing	-254M	-920M	-879M	-298M	-265M
Foreign Exchange Rate Adjustments	22.31M	14.6M	-19.64M	-2.42M	-5.09M
Net Change in Cash	170M	-61.76M	96.81M	-158M	-40.88M
Supplemental Items
Cash Interest Paid	58.44M	49.58M	38.5M	39.28M	21.9M
Cash Income Tax Paid (Refund)	153M	200M	368M	109M	148M
Levered Free Cash Flow	-97.24M	135M	556M	-285M	-145M
Unlevered Free Cash Flow	-62.33M	165M	580M	-261M	-131M
Change In Net Working Capital	13.53M	237M	-239M	72.93M	-211M
Net Debt Issued / Repaid	-9.88M	-520M	-263M	-77.63M	-12.56M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.37	13.68	11.81	4.19	4.84
Return on Total Capital	6.1	15.64	13.36	4.6	5.27
Return On Equity %	12.12	25.71	20.64	7.01	8.22
Return on Common Equity	12.12	25.71	20.64	7.01	8.22
Margin Analysis
Gross Profit Margin %	36.5	45.1	36.19	26.22	29.46
SG&A Margin	13.7	10.27	9.06	11.56	12.09
EBITDA Margin %	19.36	31.38	24.89	13.13	15.78
EBITA Margin %	17.93	30.44	23.71	11.75	14
EBIT Margin %	17.85	30.38	23.66	11.68	13.93
Income From Continuing Operations Margin %	16.22	24.84	19.72	9.89	12.21
Net Income Margin %	16.22	24.84	19.72	9.89	12.21
Net Avail. For Common Margin %	16.22	24.84	19.72	9.89	12.21
Normalized Net Income Margin	12.66	19.47	14.87	7.83	9.45
Levered Free Cash Flow Margin	-3.14	2.61	9.47	-7.05	-3.66
Unlevered Free Cash Flow Margin	-2.01	3.18	9.88	-6.44	-3.31
Asset Turnover
Asset Turnover	0.48	0.72	0.8	0.57	0.56
Fixed Assets Turnover	0.7	1.05	1.16	0.83	0.77
Receivables Turnover (Average Receivables)	11.4	16.5	19.63	15.45	11.83
Inventory Turnover (Average Inventory)	3.73	4.49	4.66	3.66	4.01
Short Term Liquidity
Current Ratio	1.52	1.6	1.51	1.29	1.21
Quick Ratio	0.58	0.56	0.62	0.51	0.64
Operating Cash Flow to Current Liabilities	0.75	1.11	1.41	0.65	0.92
Days Sales Outstanding (Average Receivables)	32.09	22.13	18.59	23.62	30.94
Days Outstanding Inventory (Average Inventory)	98.08	81.21	78.32	99.66	91.19
Average Days Payable Outstanding	44.06	25.56	18.72	22.54	23.53
Cash Conversion Cycle (Average Days)	86.11	77.78	78.2	100.75	98.61
Long Term Solvency
Total Debt/Equity	34.63	18.61	13.25	11.71	11
Total Debt / Total Capital	25.72	15.69	11.7	10.48	9.91
LT Debt/Equity	24.25	10.81	3.92	0.08	1.06
Long-Term Debt / Total Capital	18.01	9.11	3.46	0.07	0.95
Total Liabilities / Total Assets	34.45	26.82	20.4	17.49	17.52
EBIT / Interest Expense	9.91	33.08	35.91	12.05	25.14
EBITDA / Interest Expense	10.82	34.28	37.9	13.69	28.75
(EBITDA - Capex) / Interest Expense	2.25	20.15	22.09	-0.27	-6.17
Total Debt / EBITDA	2.55	0.64	0.51	1.26	1.04
Net Debt / EBITDA	1.91	0.44	0.22	0.77	0.58
Total Debt / (EBITDA - Capex)	12.22	1.08	0.87	-65.08	-4.83
Net Debt / (EBITDA - Capex)	9.15	0.74	0.38	-39.81	-2.68
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-10.84	67.31	13.13	-30.96	-2.46
Gross Profit, 1 Yr. Growth %	-18.37	106.7	-9.21	-49.98	9.59
EBITDA, 1 Yr. Growth %	-30.38	171.26	-10.28	-63.57	17.24
EBITA, 1 Yr. Growth %	-32.18	183.97	-11.87	-65.79	16.21
EBIT, 1 Yr. Growth %	-32.49	184.8	-11.89	-65.91	16.32
Earnings From Cont. Operations, 1 Yr. Growth %	-28.28	156.25	-10.19	-65.36	20.37
Net Income, 1 Yr. Growth %	-28.28	156.25	-10.19	-65.36	20.37
Normalized Net Income, 1 Yr. Growth %	-26.25	157.36	-13.62	-63.64	17.74
Diluted EPS Before Extra, 1 Yr. Growth %	-28.28	147.78	-10.93	-64.43	22.3
Accounts Receivable, 1 Yr. Growth %	-11.03	45.65	-39.65	33.05	23.18
Inventory, 1 Yr. Growth %	-8.34	51.15	10.71	-6.68	-23.71
Net Property, Plant and Equip., 1 Yr. Growth %	11.01	10.72	-6.02	0.44	8.67
Total Assets, 1 Yr. Growth %	11.22	12.38	-7.11	-0.67	2.38
Tangible Book Value, 1 Yr. Growth %	15.71	26.04	1.28	3.07	2.46
Common Equity, 1 Yr. Growth %	15.4	25.46	1.04	2.96	2.35
Cash From Operations, 1 Yr. Growth %	-12.93	68.24	8.13	-52.72	39.61
Capital Expenditures, 1 Yr. Growth %	-26.06	40.6	-9.17	-10.31	39.54
Levered Free Cash Flow, 1 Yr. Growth %	-59.98	-239.1	310.7	-151.38	-49.35
Unlevered Free Cash Flow, 1 Yr. Growth %	-67.93	-364.76	251.26	-145	-49.83
Dividend Per Share, 1 Yr. Growth %	-27.27	141.67	-5.17	-65.45	52.63
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-10.58	22.13	37.58	-11.62	-17.94
Gross Profit, 2 Yr. CAGR %	-21.05	29.9	36.99	-32.61	-25.96
EBITDA, 2 Yr. CAGR %	-30.43	37.42	56	-42.83	-34.65
EBITA, 2 Yr. CAGR %	-32.04	38.78	58.2	-45.09	-36.94
EBIT, 2 Yr. CAGR %	-32.1	38.66	58.41	-45.19	-37.03
Earnings From Cont. Operations, 2 Yr. CAGR %	-24.09	35.57	51.71	-44.23	-35.43
Net Income, 2 Yr. CAGR %	-24.11	35.57	51.71	-44.23	-35.43
Normalized Net Income, 2 Yr. CAGR %	-26.03	37.77	49.1	-43.96	-34.57
Diluted EPS Before Extra, 2 Yr. CAGR %	-23.57	33.29	48.56	-43.72	-34.05
Accounts Receivable, 2 Yr. CAGR %	5.85	13.84	-6.25	-10.39	28.02
Inventory, 2 Yr. CAGR %	-7.21	17.7	29.36	1.64	-15.63
Net Property, Plant and Equip., 2 Yr. CAGR %	10.42	10.86	2.01	-2.84	4.47
Total Assets, 2 Yr. CAGR %	5.81	11.8	2.17	-3.94	0.84
Tangible Book Value, 2 Yr. CAGR %	13.42	20.77	12.98	2.17	2.77
Common Equity, 2 Yr. CAGR %	13.02	20.33	12.59	2	2.65
Cash From Operations, 2 Yr. CAGR %	-19.64	21.03	34.87	-28.5	-18.75
Capital Expenditures, 2 Yr. CAGR %	-4.45	1.96	13.01	-9.74	11.87
Levered Free Cash Flow, 2 Yr. CAGR %	-38.48	-25.38	139.02	45.26	-48.99
Unlevered Free Cash Flow, 2 Yr. CAGR %	-55.55	-7.85	204.96	25.72	-52.49
Dividend Per Share, 2 Yr. CAGR %	-20.53	32.57	51.38	-42.76	-27.39
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.39	10.18	19.06	9.33	-8.67
Gross Profit, 3 Yr. CAGR %	-6.83	8.82	15.28	-2.09	-20.75
EBITDA, 3 Yr. CAGR %	-13.69	9.5	19.21	-3.93	-27.37
EBITA, 3 Yr. CAGR %	-14.89	9.46	19.29	-5.04	-29.5
EBIT, 3 Yr. CAGR %	-14.97	9.5	19.21	-5.07	-29.57
Earnings From Cont. Operations, 3 Yr. CAGR %	-10.58	13.87	18.18	-7.28	-27.92
Net Income, 3 Yr. CAGR %	-10.58	13.86	18.18	-7.28	-27.92
Normalized Net Income, 3 Yr. CAGR %	-12.11	12.09	17.92	-6.85	-28.22
Diluted EPS Before Extra, 3 Yr. CAGR %	-10.58	13.1	16.53	-7.76	-27.1
Accounts Receivable, 3 Yr. CAGR %	-13.55	17.74	-7.87	5.36	-0.36
Inventory, 3 Yr. CAGR %	5.94	9.18	15.32	16.02	-7.63
Net Property, Plant and Equip., 3 Yr. CAGR %	7.04	10.52	4.92	1.48	0.85
Total Assets, 3 Yr. CAGR %	5	7.96	5.1	1.22	-1.88
Tangible Book Value, 3 Yr. CAGR %	13.49	17.48	13.89	9.58	2.27
Common Equity, 3 Yr. CAGR %	12.97	17.02	13.52	9.28	2.11
Cash From Operations, 3 Yr. CAGR %	-1	2.8	16.57	-4.9	-10.63
Capital Expenditures, 3 Yr. CAGR %	-9.42	8.68	-1.89	4.63	4.37
Levered Free Cash Flow, 3 Yr. CAGR %	-34.54	-19.26	31.74	43.18	2.24
Unlevered Free Cash Flow, 3 Yr. CAGR %	-40.48	-19.42	43.95	61.15	-7.44
Dividend Per Share, 3 Yr. CAGR %	-7.17	15.14	18.56	-7.49	-20.63
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.69	23.38	14.56	0.88	2.59
Gross Profit, 5 Yr. CAGR %	10.88	28.87	8.7	-10.16	-3.43
EBITDA, 5 Yr. CAGR %	7.74	33.82	9.37	-15.57	-6.27
EBITA, 5 Yr. CAGR %	7.62	34.94	9.06	-16.93	-7.56
EBIT, 5 Yr. CAGR %	7.52	34.89	9.06	-16.98	-7.65
Earnings From Cont. Operations, 5 Yr. CAGR %	13.26	42.89	10.47	-14.41	-7.2
Net Income, 5 Yr. CAGR %	13.26	42.89	10.47	-14.42	-7.2
Normalized Net Income, 5 Yr. CAGR %	11.99	37.25	8.58	-15.05	-6.83
Diluted EPS Before Extra, 5 Yr. CAGR %	13.26	41.93	9.54	-14.45	-7.2
Accounts Receivable, 5 Yr. CAGR %	14.11	11.15	-10.7	5.56	5.09
Inventory, 5 Yr. CAGR %	19.53	26.88	14.75	6.1	1.77
Net Property, Plant and Equip., 5 Yr. CAGR %	7.32	9.37	5	4.97	4.74
Total Assets, 5 Yr. CAGR %	7.96	9.9	3.86	3.03	3.38
Tangible Book Value, 5 Yr. CAGR %	13.13	18.52	13.29	11.1	9.3
Common Equity, 5 Yr. CAGR %	13.62	18.94	12.82	10.76	9.04
Cash From Operations, 5 Yr. CAGR %	6.32	22.04	12.04	-11.1	0.89
Capital Expenditures, 5 Yr. CAGR %	-1.16	4.49	-1.04	0.9	3.4
Levered Free Cash Flow, 5 Yr. CAGR %	-22.03	-9.55	9.89	2.12	-9.86
Unlevered Free Cash Flow, 5 Yr. CAGR %	-28.18	-4.52	14.42	-3.73	-7.6
Dividend Per Share, 5 Yr. CAGR %	14.87	45.16	12.89	-12.94	-2.55